Literature DB >> 16061264

Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction.

David C S Roberts1.   

Abstract

A variety of studies indicate that GABA(B) receptor agonists may be useful in the treatment of addictive disorders. This brief review summarizes self-administration studies in rats which show that baclofen and other GABA(B) agonists may have specific effects on the reinforcing effects of cocaine. Preliminary clinical data with baclofen have also been encouraging. The obstacles and issues related to the use of GABA drugs in addiction therapy are briefly addressed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061264     DOI: 10.1016/j.physbeh.2005.06.017

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  28 in total

Review 1.  Too much of a good thing: neurobiology of non-homeostatic eating and drug abuse.

Authors:  Rebecca L Corwin; Andras Hajnal
Journal:  Physiol Behav       Date:  2005-09-15

2.  GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus.

Authors:  Xinmin Xie; Tara L Crowder; Akihiro Yamanaka; Stephen R Morairty; Robin D Lewinter; Takeshi Sakurai; Thomas S Kilduff
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

Review 3.  Microdialysis and the neurochemistry of addiction.

Authors:  Mary M Torregrossa; Peter W Kalivas
Journal:  Pharmacol Biochem Behav       Date:  2007-09-12       Impact factor: 3.533

4.  Use of animal models to develop antiaddiction medications.

Authors:  Eliot L Gardner
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

5.  Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep.

Authors:  Zachary D Brodnik; David L Bernstein; Courtney D Prince; Rodrigo A España
Journal:  Behav Brain Res       Date:  2015-06-03       Impact factor: 3.332

Review 6.  Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint?

Authors:  Joseph Frascella; Marc N Potenza; Lucy L Brown; Anna Rose Childress
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

7.  Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals.

Authors:  Helen Fox; Mehmet Sofuoglu; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2015-01-07       Impact factor: 4.153

8.  Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats.

Authors:  Gregory P Mark; Anthony E Kinney; Michele C Grubb; Xiaoman Zhu; Deborah A Finn; Sarah L Mader; S Paul Berger; Anita J Bechtholt
Journal:  Brain Res       Date:  2006-10-13       Impact factor: 3.252

9.  Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patients.

Authors:  Klevest Gjini; Ulf Ziemann; T Celeste Napier; Nash Boutros
Journal:  J Psychiatr Res       Date:  2011-10-27       Impact factor: 4.791

10.  Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.

Authors:  Elena Martín-García; Lucie Bourgoin; Adeline Cathala; Fernando Kasanetz; Miguel Mondesir; Ana Gutiérrez-Rodriguez; Leire Reguero; Jean-François Fiancette; Pedro Grandes; Umberto Spampinato; Rafael Maldonado; Pier Vincenzo Piazza; Giovanni Marsicano; Véronique Deroche-Gamonet
Journal:  Neuropsychopharmacology       Date:  2015-11-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.